Skip to main content
Fig. 5 | Lipids in Health and Disease

Fig. 5

From: Cytosolic phospholipase A2 (cPLA2) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages

Fig. 5

PLA2 activity at 50 μg/ml of CSC concentration alone or in combinations with PLA2 isoforms specific inhibitors at 24 h of treatment time in A549 cells (a) and WI26 cells (b). The decrease in absorbance is directly proportional to PLA2 activity. The results are expressed as mean ± SD of three separate experiments. *,#p < 0.05. *CSC 50 μg/ml activity response compared with their respective control at every minutes interval. #CSC 50 μg/ml in combination with cPLA2 specific inhibitor (ATK) activity response compared with their respective CSC 50 μg/ml alone at every minutes interval

Back to article page